洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2000038865】Does elective orthopaedic surgery in the pandemic era increase the risk of developing COVID-19? A combined analysis of retrospective and prospective study at a national tertiary hospital in Jakarta, Indonesia

基本信息
登记号

ChiCTR2000038865

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2020-10-07

临床申请受理号

/

靶点

/

适应症

新型冠状病毒肺炎(COVID-19)

试验通俗题目

Does elective orthopaedic surgery in the pandemic era increase the risk of developing COVID-19? A combined analysis of retrospective and prospective study at a national tertiary hospital in Jakarta, Indonesia

试验专业题目

Does elective orthopaedic surgery in the pandemic era increase the risk of developing COVID-19? A combined analysis of retrospective and prospective study at a national tertiary hospital in Jakarta, Indonesia

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

10430

联系人通讯地址
临床试验信息
试验目的

This study aims to investigate whether elective orthopaedic surgery will increase the risk of developing COVID-19.

试验分类
试验类型

连续入组

试验分期

回顾性研究

随机化

No randomization was performed

盲法

No blinding was performed

试验项目经费来源

The authors report no external source of funding during the writing of this article.

试验范围

/

目标入组人数

35

实际入组人数

/

第一例入组时间

2020-07-01

试验终止时间

2020-08-31

是否属于一致性

/

入选标准

Subjects were patients who underwent elective orthopaedic surgeries at our institution from April to May 2020;

排除标准

Those who were previously infected with COVID-19 from polymerase chain reaction (PCR) reverse transcriptase (RT) examination obtained via nasopharynx and oropharynx swab, as well as those who were reluctant to participate, were excluded from the study.;

研究者信息
研究负责人姓名
试验机构

None

研究负责人电话
研究负责人邮箱
研究负责人邮编

10430

联系人通讯地址
<END>

None的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品

同适应症药物临床试验